Investing in Auris Medical Holding Ltd. (NASDAQ:EARS) Stock. EARS Performance & Trends

In the latest trading session, 1,376,589 Auris Medical Holding Ltd.(NASDAQ:EARS) shares changed hands as the company’s beta touched 1.21. With the company’s most recent per share price at $3.4 changing hands around $0.25 or 0.08% at last look, the market valuation stands at $38.02 Million. EARS’s current price is a discount, trading about -94.12% off its 52-week high of $6.6. The share price had its 52-week low at $0.65, which suggests the recent value is80.88% up since then. When we look at Auris Medical Holding Ltd.’s average trading volume, we note the 10-day average is 3.15 Million shares, with the 3-month average coming to 6.49 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts gave the Auris Medical Holding Ltd. (EARS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 0. If we narrow down to specifics, the data shows that none out of 1 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended EARS as a Hold, 1 felt it is a Buy and none rated the stock as Underweight. Auris Medical Holding Ltd.’s EPS for the current quarter is expected to be $0.

Instantly EARS is in green as seen in intraday trades today. With action 8.1%, the performance over the past five days has been green. The jump to weekly highs of $3.83- on Friday, Jan 22 added 8.51% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.34%, with the 5-day performance at 0.33% in the green. However, in the 30-day time frame, Auris Medical Holding Ltd. (NASDAQ:EARS) is 0.17% up. Looking at the short shares, we see there were 44.64 Million shares sold at short interest cover period of 6.88 days.

The consensus price target for the stock as assigned by Wall Street analysts is $14.3, meaning bulls need an upside of 320.59% from its recent market value. According to analyst projections, EARS’s forecast low is $14.3 with $14.3 as the target high. To hit the forecast high, the stock’s price needs a +320.59% upsurge from its latest level, while the stock would need to tank 320.59% for it to hit the projected low.

Auris Medical Holding Ltd. (EARS) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 55.5%. The 2021 estimates are for Auris Medical Holding Ltd. earnings to increase by 84.2%, but the outlook for the next 5-year period is at 0% per year.

Auris Medical Holding Ltd. (NASDAQ:EARS)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 6.05% of Auris Medical Holding Ltd. shares while 0.48% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.51%. There are 7 institutions holding the Auris Medical Holding Ltd. stock share, with HRT Financial LLC the top institutional holder. As of Sep 29, 2020, the company held 0.32% of the shares, roughly 23.85 Thousand EARS shares worth $19.27 Thousand.

Susquehanna International Group, LLP holds the second largest percentage of outstanding shares, with 0.17% or 12.51 Thousand shares worth $10.11 Thousand as of Sep 29, 2020.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on..

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Latest posts